These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Erythromycin and clindamycin absorption and elimination in pregnant women. Philipson A; Sabath LD; Charles D Clin Pharmacol Ther; 1976 Jan; 19(1):68-77. PubMed ID: 1245094 [TBL] [Abstract][Full Text] [Related]
27. Clinical pharmacological studies with the vasodilator endralazine in patients with renal impairment. Elliott HL; Meredith PA; Sloan L; Reid JL Eur J Clin Pharmacol; 1984; 27(2):159-63. PubMed ID: 6499896 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of flupirtine in elderly volunteers and in patients with moderate renal impairment. Abrams SM; Baker LR; Crome P; White AS; Johnston A; Ankier SI; Warrington SJ; Turner P; Niebch G Postgrad Med J; 1988 May; 64(751):361-3. PubMed ID: 3200777 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis. Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079 [TBL] [Abstract][Full Text] [Related]
30. An overview of the pharmacology of intravenously administered ciprofloxacin. Drusano GL Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function. Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of intravenously administered tobramycin in normal volunteers and in renal-impaired and hemodialyzed patients. Péchère JC; Dugal R J Infect Dis; 1976 Aug; 134 Suppl():S118-24. PubMed ID: 972269 [TBL] [Abstract][Full Text] [Related]
33. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function. Nilsen OG; Saltvedt E; Walstad RA; Marstein S Am J Med; 1992 Apr; 92(4A):38S-40S. PubMed ID: 1316068 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of sulpiride after intravenous administration in patients with impaired renal function. Bressolle F; Brès J; Mourad G Clin Pharmacokinet; 1989 Nov; 17(5):367-73. PubMed ID: 2582694 [TBL] [Abstract][Full Text] [Related]
35. Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis. Kosmidis J; Doundoulaki P; Stathakis C; Zerefos N; Bounia A; Daikos GK Arzneimittelforschung; 1979; 29(12a):1960-2. PubMed ID: 543901 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment. Flor S; Guay D; Opsahl J; Tack K; Matzke G Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697 [TBL] [Abstract][Full Text] [Related]
37. Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans. Chen L; Greenberg WM; Brand-Schieber E; Wangsa J; Periclou A; Ghahramani P Drug Des Devel Ther; 2015; 9():3293-300. PubMed ID: 26150701 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment. Shi J; Montay G; Chapel S; Hardy P; Barrett JS; Sack M; Marbury T; Swan SK; Vargas R; Leclerc V; Leroy B; Bhargava VO J Clin Pharmacol; 2004 Mar; 44(3):234-44. PubMed ID: 14973302 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of repaglinide in subjects with renal impairment. Marbury TC; Ruckle JL; Hatorp V; Andersen MP; Nielsen KK; Huang WC; Strange P Clin Pharmacol Ther; 2000 Jan; 67(1):7-15. PubMed ID: 10668848 [TBL] [Abstract][Full Text] [Related]